Phase II Study of Vinorelbine Plus Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes.
| Author | |
|---|---|
| Abstract |
:
The role of first-line trastuzumab-based therapy has been firmly established in patients with human epidermal growth factor receptor-2 (HER2) positive metastatic breast cancer. In this trial, we evaluated the efficacy and safety of a vinorelbine and trastuzumab combination chemotherapy in patients who were pretreated with anthracyclines and taxanes. |
| Year of Publication |
:
2011
|
| Journal |
:
Journal of breast cancer
|
| Volume |
:
14
|
| Issue |
:
2
|
| Number of Pages |
:
140-6
|
| Date Published |
:
2011 Jun
|
| ISSN Number |
:
1738-6756
|
| DOI |
:
10.4048/jbc.2011.14.2.140
|
| Short Title |
:
Phase II Study of Vinorelbine Plus Trastuzumab in HER2 Overexpre
|
| Download citation |
